OOIR: Observatory of International Research

Papers

(The TQCC of Clinical and Translational Radiation Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Stabilised Hyaluronic Acid (sHA) gel as a novel marker for breast cancer tumour bed cavity: Surgical feasibility	44
Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma	29
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments	26
Machine learning for dose-volume histogram based clinical decision-making support system in radiation therapy plans for brain tumors	22
Influence of intestinal microbial metabolites on the abscopal effect after radiation therapy combined with immune checkpoint inhibitors	21
Uterus motion analysis for radiotherapy planning optimization. The innovative contribution of on-board hybrid MR imaging	21
Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how	16
Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan	15
Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer	13
Long-term outcomes of more than a decade treating patients with stereotactic body radiation therapy for hepatocellular carcinoma	13
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac	13
Avoiding prostate bed radiation for the PSMA-PET detected nodal recurrence patient post prostatectomy	13
Blood-brain barrier permeability following conventional photon radiotherapy – A systematic review and meta-analysis of clinical and preclinical studies	12
Effectiveness, toxicity and impact on quality of life of high-dose-rate brachytherapy delivered in two fractions as monotherapy in patients with prostate cancer	11
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)	11
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial	11
Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer	11
Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study	11
Radiation response assessment of organoids derived from patients with pancreatic cancer	10
Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity	9
Association between radiotherapy protocol variations and outcome in the CONVERT trial	9
A fully automated machine-learning-based workflow for radiation treatment planning in prostate cancer	9
Integrative prediction model for radiation pneumonitis incorporating genetic and clinical-pathological factors using machine learning	9
Predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients using a deep learning model	9
Comparing supervised and semi-supervised machine learning approaches in NTCP modeling to predict complications in head and neck cancer patients	8

Comparison of 18F-FET-PET- and MRI-based target definition for re-irradiation treatment of recurrent diffuse glioma	8
Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment	8
Comparison of simultaneous integrated tumor bed boost and sequential boost during hypofractionated whole-breast irradiation after breast-conserving surgery	8
Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer	8
A retrospective review of the long-term outcomes of online adaptive radiation therapy and conventional radiation therapy for muscle invasive bladder cancer	8
Investigation of the physiological response of radiation-induced cystitis patients using hyperbaric oxygen	7
Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)	7
A single-institution phase I feasibility study of dose-escalated IMRT for non-operative locally advanced esophageal carcinoma	7
Comparative effectiveness of new treatment modalities for localized prostate cancer through patient-reported outcome measures	7
The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset	7
Outcomes and predictors of response to fractionated radiotherapy as primary treatment for intracranial meningiomas	7
Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC	6
MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study	6
Setting the stage: The opening act of preoperative SRS for brain metastases	6
Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration‐resistant prostate cancer patients – A closer inspection will improve your vision	6
Morphological changes after cranial fractionated photon radiotherapy: Localized loss of white matter and grey matter volume with increasing dose	6
Artificial intelligence to predict outcomes of head and neck radiotherapy	6
Stereotactic ablative radiotherapy for treating primary head and neck cancer and locoregional recurrence: A comprehensive review of the literature	6
In regard to Kim et al	6
Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial	6
The prognostic utility of IGF-1 in hepatocellular carcinoma treated with stereotactic body radiotherapy	6
Acute toxicity patterns and their management after moderate and ultra- hypofractionated radiotherapy for prostate cancer: A prospective cohort study	6
Metastases-directed radiotherapy in castration resistant oligo metastatic prostate cancer: A multicentric retrospective study from the French group COLib	6
The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change?	6
Corrigendum to “Bridging the care gap: patients’ needs and experiences regarding shared decision-making in radiotherapy” [Clin. Translat. Radiat. Oncol. (2025) 100897]	6
Feasibility of low-dose radiotherapy for patients with stage I/II extranodal NK-/T-cell lymphoma, nasal type achieving complete response after l-asparaginase-containing chemotherapy	6
Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma	5
The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey	5
Quantifying radiation-induced breast fibrosis by shear-wave elastography in patients with breast cancer: A 12-months-follow-up data of a prospective study	5
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer	5
Does a peer review group consensus process for MR-Linac patients affect clinical care? Evaluation of impact and feasibility	5
Acute toxicities in proton therapy for head and neck cancer – A matched analysis of the DAHANCA 35 feasibility study	5
Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation	5
Complications leading to hospitalisation 12 months after brachytherapy or high-intensity focused ultrasound for localized prostate cancer: French national from the PMSI-MCO data, 2019 and 2020	5
Clinical outcomes of esophageal squamous cell carcinoma in patients with cirrhosis	5
Randomized clinical trial of tissue equivalent bolus prescription in postmastectomy radiotherapy stratified by skin involvement status	5
Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac	5
Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinoma	5
Concurrent palliative radiation with pembrolizumab for platinum-refractory urothelial carcinoma is associated with improved overall survival	5
Prolonging deep inspiration breath-hold time to 3 min during radiotherapy, a simple solution	5
Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI	5
Clinical management of oligometastatic cancer: Applying multidisciplinary tumor board recommendations in practice	5
Deterioration of pancreatic exocrine function in carbon ion radiotherapy for pancreatic cancer	5
Salvage LATTICE radiotherapy for a growing tumour despite conventional radio chemotherapy treatment of lung cancer	5
Risk of stroke-specific mortality after radiotherapy in patients with primary brain tumours	5
Artificial intelligence guided physician directive improves head and neck planning quality and practice Uniformity: A prospective study	4
Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis	4
Mepitel® film versus standard care for the prevention of skin toxicity in breast cancer patients treated with adjuvant radiotherapy: A randomized controlled trial	4
Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer	4
Determining risk and predictors of head and neck cancer treatment-related lymphedema: A clinicopathologic and dosimetric data mining approach using interpretable machine learning and ensemble feature	4

The carbon footprint of external beam radiotherapy and its impact in health technology assessment	4
Bridging the care gap: patients’ needs and experiences regarding shared decision-making in radiotherapy	4
Impact of pretreatment second look 18FDG-PET/CT on stage and treatment changes in head and neck cancer	4
C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect	4
The need for consensus on delineation and dose constraints of dentofacial structures in paediatric radiotherapy: Outcomes of a SIOP Europe survey	4
Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia	4
Access to brachytherapy treatment for cervical cancer management in Africa	4
Supraventricular cardiac conduction system exposure in breast cancer patients treated with radiotherapy and association with heart and cardiac chambers doses	4
Letter to the Editor	4
A prospective study assessing the pattern of response of local disease at DCE-MRI after salvage radiotherapy for prostate cancer	4
Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise	4
GI factors, potential to predict prostate motion during radiotherapy; a scoping review	4
Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer	4
Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy	4
Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study	4
Outcomes and predictive factors after second stereotactic radiosurgery for refractory trigeminal neuralgia	4
Postoperative complications after esophagectomy for cancer, neoadjuvant chemoradiotherapy compared to neoadjuvant chemotherapy: A single institutional cohort study	4
Postoperative radiotherapy alone is as effective as postoperative chemoradiotherapy in patients with pT4aN0 gingival cancer with negative surgical margins	4
Irradiation of localized prostate cancer in the elderly: A systematic literature review	4
Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases – Clinical outcome and prognostic factors	4
Cervical body composition on radiotherapy planning computed tomography scans predicts overall survival in glioblastoma patients	4
Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study	4
Prospective evaluation of intensity-modulated radiotherapy toxicity in extremity soft tissue sarcomas patients: A role for irradiated healthy soft tissue volume?	4
Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey	4
Reproducibility of Deep-Inspiration Breath Hold treatments on Halcyon™ performed using the first clinical version of AlignRT InBore™: Results of CYBORE study	4
Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience	4
Multidisciplinary Treatment of Non-Spine Bone Metastases: Results of a Modified Delphi Consensus Process	4
Enhancing radiotherapy outcomes in rectal cancer: A systematic review of targeting hypoxia-induced radioresistance	4
Predicting the benefit of stereotactic body radiotherapy of colorectal cancer metastases	4
Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis	4
MucoUp® as a spacer in brachytherapy for uterine cervical cancer: A first-in-human experience	4
External validation of pulmonary radiotherapy toxicity models for ultracentral lung tumors	3
Dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors using a gimbal-mounted linac: A multi-institutional phase II study	3
Real-world utilisation of brachytherapy boost and patient-reported functional outcomes in men who had external beam radiation therapy for prostate cancer in Australia	3
Personalized neck irradiation guided by sentinel lymph node biopsy in patients with squamous cell carcinoma of the oropharynx, larynx or hypopharynx with a clinically negative neck: (Chemo)radiotherap	3
SABR for oligometastatic renal cell carcinoma	3
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation	3
Factors associated with complex oral treatment device usage in patients with head and neck cancer	3
Health care system factors associated with receipt of treatment and treatment intent in stage III non-small cell lung cancer: A population-based study in Ontario	3
Clinical outcomes and risk factors for local failure and visual impairment in patients treated with Ru-106 brachytherapy for uveal melanoma	3
MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study	3
A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic	3
The technical design and concept of a PET/CT linac for biology-guided radiotherapy	3
Adjuvant PD-1 antibody in recurrent, previously irradiated oral cavity cancer treated with salvage surgery	3
Incidental dose distribution to contralateral internal mammary nodes in breast cancer patients undergoing adjuvant radiotherapy	3
Design and evaluation of a deep learning-based automatic segmentation of maxillary and mandibular substructures using a 3D U-Net	3
Thyroid volume changes following adjuvant radiation therapy for breast cancer	3
Institutional experience of using active breathing control for paediatric and teenage patients receiving thoraco-abdominal radiotherapy	3
Impact of endorectal filling on interobserver variability of MRI based rectal primary tumor delineation	3
Salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy	3
Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: Acute toxicity results	3
Lung cancer epidermal growth factor receptor mutations and radiotherapy response: A multicentre clinical study	3
Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy	3
Cleaning radiotherapy contours for radiomics studies, is it worth it? A head and neck cancer study	3
Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study	3
Comment on Hunt et al., “Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer”	3
Long-term outcomes of an esophagus-preserving chemoradiotherapy strategy for patients with endoscopically unresectable stage I thoracic esophageal squamous cell carcinoma	3
Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplana	3
Biopsy-derived oral keratinocytes – A model to potentially test for oral mucosa radiation sensitivity	3
Reply to: Comment on “Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease”	3
Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach	3
Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population	3
Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer	3
Radiotherapy-induced Hypothalamic-Pituitary axis dysfunction in adult Brain, head and neck and skull base tumor patients – A systematic review and Meta-Analysis	3
An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases	3
Adaptive radiotherapy for breast cancer	3
Cosmetic outcome in patients with early stage breast cancer after accelerated partial breast irradiation using intraoperative or external beam radiotherapy	3
Prospective radiotherapy quality Assurance leads to delineation guideline refinements for recurrent rectal cancer: Experience from the PelvEx II study	3
Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases	3
#radonc: Growth of the global radiation oncology Twitter network	3
Pelvic insufficiency fractures after intensity modulated radiation therapy combined with chemotherapy for cervix carcinoma: Incidence and impact of bone mineral density	3
Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer	3
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospecti	3
The oxygen puzzle in FLASH radiotherapy: A comprehensive review and experimental outlook	3